Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katy H. P. Moore
Observed names:
K. H. P. Moore,
K.H.P. Moore,
K. H. P. Moore,
Katy H.P. Moore,
Katy HP Moore,
Katy Moore
show all 6
Observed institutions:
University of North Carolina at Chapel Hill,
Joint United Nations Programme on HIV/AIDS,
University of Liverpool,
GlaxoSmithKline (United States),
Sciences Po Aix,
BC Centre for Excellence in HIV/AIDS,
University of KwaZulu-Natal
show all 7
OpenAlex ID:
A5111754267
Clinical Pharmacokinetics of Lamivudine
1999
·
Mark A. Johnson
, Katy H.P. Moore
, et al.
·
Clinical Pharmacokinetics
·
282
Pharmacokinetics and Antiretroviral Activity of Lamivudine Alone or When Coadministered with Zidovudine in Human Immunodeficiency Virus Type 1–Infected Pregnant Women and Their Offspring
1998
·
J. Moodley
, D. Moodley
, et al.
·
The Journal of Infectious Diseases
·
193
PDF
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole*
1996
·
Katy H. P. Moore
, Geoffrey J. Yuen
, et al.
·
Clinical Pharmacology & Therapeutics
·
133
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1
1999
·
Katy H. P. Moore
, Jo E. Barrett
, et al.
·
AIDS
·
128
Phosphorylation of Nucleoside Analog Antiretrovirals: A Review for Clinicians
2001
·
Daniel S. Stein
, Katy H. P. Moore
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
116
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection
2018
·
Romina Quercia
, Carlo-Federico Perno
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
114
Clinical Pharmacokinetics of Intranasal Sumatriptan
2002
·
Eliane Fuseau
, Olivier Petricoul
, et al.
·
Clinical Pharmacokinetics
·
69
Pharmacokinetics of Zidovudine and Lamivudine in Neonates following Coadministration of Oral Doses Every 12 Hours
2001
·
Daya Moodley
, Kuben Pillay
, et al.
·
The Journal of Clinical Pharmacology
·
61
Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption
1999
·
Katy H. P. Moore
, Shuching Shaw
, et al.
·
The Journal of Clinical Pharmacology
·
53
Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials
1999
·
Katy H. P. Moore
, Geoffrey J. Yuen
, et al.
·
Antimicrobial Agents and Chemotherapy
·
43
PDF
Statistical Issues in a Modeling Approach to Assessing Bioequivalence or PK Similarity with Presence of Sparsely Sampled Subjects
2004
·
Chuanpu Hu
, Katy H. P. Moore
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
34
The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers
2001
·
Lindsey M. Cass
, Katy H. P. Moore
, et al.
·
The Journal of Clinical Pharmacology
·
29
Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood
2000
·
Chaiporn Bhadrakom
, R. J. Simonds
, et al.
·
AIDS
·
28
Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation
2002
·
G. L. Drusano
, K. H. P. Moore
, et al.
·
Antimicrobial Agents and Chemotherapy
·
23
Metabolic Disposition and Pharmacokinetics of [14C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
2001
·
Brian M. Sadler
, Gregory E. Chittick
, et al.
·
The Journal of Clinical Pharmacology
·
22
The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers
2002
·
Katy H.P. Moore
, Philip T. Leese
, et al.
·
Clinical Therapeutics
·
18
A Population Pharmacokinetic Analysis of Zanamivir in Subjects with Experimental and Naturally Occurring Influenza: Effects of Formulation and Route of Administration
2000
·
Amy W. Peng
, Elizabeth K. Hussey
, et al.
·
The Journal of Clinical Pharmacology
·
18
GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine
2001
·
Keikawus Arasteh
, Robin Wood
, et al.
·
HIV Clinical Trials
·
14
Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor
2001
·
K.H.P. Moore
, L.M. Cass
, et al.
·
European Journal of Clinical Pharmacology
·
9
The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers
2002
·
Katy H.P. Moore
, Scott McNeal
, et al.
·
Clinical Therapeutics
·
8
High-Performance Liquid Chromatographic Evaluation of the Effect of Heat Treatment on Trimethoprim and Sulfamethoxazole Stability in Serum
1995
·
Katy H. P. Moore
, Kim L. R. Brouwer
·
Therapeutic Drug Monitoring
·
3
Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers
2001
·
Katy H. P. Moore
, Lindsey M. Cass
, et al.
·
The Journal of Clinical Pharmacology
·
2
Lessons Gained from Distance Delivery of an Applied Pharmacokinetics Course
1997
·
Katy H.P. Moore
, Kim L.R. Brouwer
, et al.
·
American Journal of Pharmaceutical Education
·
1
The Comeback Kid
2013
·
A.R. Gilman
, Katy H. P. Moore
, et al.
·
Iowa State University Digital Repository (Iowa State University)
PDF
Effect of high fat and normal meals on the relative bioavailability of GW420867X 100-mg administered as a single oral dose to healthy volunteers
1999
·
Lindsey Cass
, Katy H. P. Moore
, et al.
·
Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy
Show more works
View as search
Works count:
26
Citation count:
1,401
H-index:
17
I10-index:
18
Year
Topic
Type
